Cargando…
Rethinking the immunotherapy numbers game
Immunotherapies are a major breakthrough in oncology, yielding unprecedented response rates for some cancers. Especially in combination with conventional treatments or targeted agents, immunotherapeutics offer invaluable tools to improve outcomes for many patients. However, why not all patients have...
Autores principales: | Bekker, Rebecca A, Zahid, Mohammad U, Binning, Jennifer M, Spring, Bryan Q, Hwu, Patrick, Pilon-Thomas, Shari, Enderling, Heiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260835/ https://www.ncbi.nlm.nih.gov/pubmed/35793871 http://dx.doi.org/10.1136/jitc-2022-005107 |
Ejemplares similares
-
Mathematical modeling of radiotherapy and its impact on tumor interactions with the immune system
por: Bekker, Rebecca Anne, et al.
Publicado: (2022) -
Rethinking Sesquiterpenoids: A Widespread Hormone in Animals
por: So, Wai Lok, et al.
Publicado: (2022) -
Comparative Study of different msDNA (multicopy single-stranded DNA) structures and phylogenetic comparison of reverse transcriptases (RTs): evidence for vertical inheritance
por: Das, Rasel, et al.
Publicado: (2011) -
Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy
por: Malczewski, Agnieszka Beata, et al.
Publicado: (2020) -
T follicular helper cells: linking cancer immunotherapy and immune-related adverse events
por: Baumjohann, Dirk, et al.
Publicado: (2021)